LINDSAY FORRESTER: Open Payments
NPI 1023447984 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 29 payments from 9 companies in 2025. Trend: 2023 $621 · 2024 $733 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $314 |
| Otsuka America Pharmaceutical, Inc. | 4 | $96 |
| Philips North America LLC | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Amgen Inc. | 2 | $35 |
| Novo Nordisk Inc | 2 | $32 |
| Exact Sciences Corporation | 2 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
Products named: AIRSUPRA, REXULTI, Vest Therapy Und, Auvelity, OTEZLA, Wegovy, Cologuard Collection Kit, BREZTRI.
Industry payments across KS — which companies pay providers there.
